Current and Future Pathways in Aspergillus Diagnosis-Reference-Cited by-同舟云学术

Current and Future Pathways in Aspergillus Diagnosis

Published:2023-02-13 Issue:2 Volume:12 Page:385
ISSN:2079-6382
Container-title:Antibiotics
language:en
Short-container-title:Antibiotics

Author:

Dobiáš Radim¹²^ORCID,Stevens David A.³⁴,Havlíček Vladimír⁵⁶^ORCID

Affiliation:

1. Department of Bacteriology and Mycology, Public Health Institute in Ostrava, Partyzánské Náměstí 2633/7, 702 00 Ostrava, Czech Republic

2. Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic

3. California Institute for Medical Research, 2260 Clove Drive, San Jose, CA 95128, USA

4. Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 95128, USA

5. Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic

6. Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. Listopadu 12, 771 46 Olomouc, Czech Republic

Abstract

Aspergillus fumigatus has been designated by the World Health Organization as a critical priority fungal pathogen. Some commercially available diagnostics for many forms of aspergillosis rely on fungal metabolites. These encompass intracellular molecules, cell wall components, and extracellular secretomes. This review summarizes the shortcomings of antibody tests compared to tests of fungal products in body fluids and highlights the application of β-d-glucan, galactomannan, and pentraxin 3 in bronchoalveolar lavage fluids. We also discuss the detection of nucleic acids and next-generation sequencing, along with newer studies on Aspergillus metallophores.

Funder

Czech Science Foundation

Internal Grant Agency of the University of Ostrava

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Link

https://www.mdpi.com/2079-6382/12/2/385/pdf

Reference84 articles.

1. World Health Organization (2022, November 11). Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Available online: https://www.who.int/publications/i/item/9789240060241.

2. The spectrum of pulmonary aspergillosis;Kanj;Respir. Med.,2018

3. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group;Bassetti;Clin. Infect. Dis.,2021

4. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: A Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study;Giacobbe;J. Clin. Microbiol.,2022

5. Pulmonary Aspergillosis: What the Generalist Needs to Know;Gao;Am. J. Med.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil;Mycopathologia;2024-06

2. Interplay of Cytokines and Chemokines in Aspergillosis;Journal of Fungi;2024-03-27

3. New Breath Diagnostics for Fungal Disease;Current Clinical Microbiology Reports;2024-02-07

4. Rapid SERS detection of diverse filamentous fungi by superparamagnetic particles and flexible silver nanowires;Sensing and Bio-Sensing Research;2023-12

5. Targeting Aspergillus allergen oryzin with a chemical probe at atomic precision;Scientific Reports;2023-10-20